106 related articles for article (PubMed ID: 3068033)
81. Free radical mechanisms in chemical pathogenesis. Summary of the symposium presented at the 1988 annual meeting of the Society of Toxicology.
Kehrer JP; Mossman BT; Sevanian A; Trush MA; Smith MT
Toxicol Appl Pharmacol; 1988 Sep; 95(3):349-62. PubMed ID: 3188006
[No Abstract] [Full Text] [Related]
82. The infrared examination of compounds related to ascorbic acid.
TROTTER IF; THOMPSON HW; WOKES F
Biochem J; 1948; 42(4):601. PubMed ID: 18876942
[No Abstract] [Full Text] [Related]
83. Redoxon Roche.
Roche Rev; 1946 May; 3():61. PubMed ID: 20995664
[No Abstract] [Full Text] [Related]
84. The ascorbic acid content of the adrenals and livers of different animals.
Svirbely JL
Biochem J; 1933; 27(3):960-3. PubMed ID: 16745179
[No Abstract] [Full Text] [Related]
85. FACTORS THAT INFLUENCE THE PASSAGE OF ASCORBIC ACID FROM SERUM TO CELLS IN HUMAN BLOOD.
Heinemann M; Hald PM
J Clin Invest; 1940 May; 19(3):469-73. PubMed ID: 16694762
[No Abstract] [Full Text] [Related]
86. On the physiological action of ascorbic acid and some related compounds.
Demole V
Biochem J; 1934; 28(3):770-3. PubMed ID: 16745460
[No Abstract] [Full Text] [Related]
87. The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q.
Beyer RE
J Bioenerg Biomembr; 1994 Aug; 26(4):349-58. PubMed ID: 7844109
[TBL] [Abstract][Full Text] [Related]
88. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
Gutierrez PL
Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
[TBL] [Abstract][Full Text] [Related]
89. Free radicals in toxicology.
Aust SD; Chignell CF; Bray TM; Kalyanaraman B; Mason RP
Toxicol Appl Pharmacol; 1993 Jun; 120(2):168-78. PubMed ID: 8511786
[TBL] [Abstract][Full Text] [Related]
90. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
Nguyen B; Biswal S; Gutierrez PL
Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
[TBL] [Abstract][Full Text] [Related]
91. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
[TBL] [Abstract][Full Text] [Related]
92. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
Gutierrez PL; Fox BM; Mossoba MM; Bachur NR
Mol Pharmacol; 1984 Nov; 26(3):582-6. PubMed ID: 6092903
[TBL] [Abstract][Full Text] [Related]
93. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
[TBL] [Abstract][Full Text] [Related]
94. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Friedman RD; Bachur NR
Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
[TBL] [Abstract][Full Text] [Related]
95. The influence of ascorbic acid on the free-radical metabolism of xenobiotics: the example of diaziquone.
Gutierrez PL
Drug Metab Rev; 1988; 19(3-4):319-43. PubMed ID: 3068033
[TBL] [Abstract][Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
